Company · OCUL · CIK 1393434

Ocular Therapeutix, Inc (OCUL) SEC filings and CIK.

OCUL’s SEC Central Index Key (CIK) is 0001393434, or 1393434 without leading zeros. The SEC’s ticker file lists it as OCULAR THERAPEUTIX, INC.

Ticker
OCUL
CIK
0001393434
Other tickers
None
Insider transactions, Q3 2026
7

Insider trading

In Q3 2026, insiders at Ocular Therapeutix, Inc reported 7 non-derivative transactions on 5 Forms 3, 4 and 5, including 0 open-market purchases and 5 sales. See every OCUL insider transaction →

Recent filings we observed

From our record of EDGAR’s latest-filings feed and sampled daily indexes. Not a complete filing history; use the filings API for that.
FiledFormAccession
2026-11-09S-80001104659-26-124187
2026-11-098-K0001104659-26-124159
2026-11-0910-Q0001104659-26-124155
2026-11-098-K0001104659-26-124151

Get OCUL SEC data through the API

Filing history
curl "https://sec-api.dev/api/v1/filings?cik=1393434&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"
Company profile
curl "https://sec-api.dev/api/v1/companies/1393434" \
  -H "Authorization: Bearer $SEC_API_KEY"
Reported XBRL facts
curl "https://sec-api.dev/api/v1/facts/1393434?taxonomy=us-gaap&concept=Revenues&limit=10" \
  -H "Authorization: Bearer $SEC_API_KEY"

Ticker to CIK API · SEC filings API · Ocular Therapeutix, Inc on SEC.gov

Questions

What is OCUL’s CIK number?

OCUL’s SEC Central Index Key (CIK) is 0001393434, or 1393434 without leading zeros. The SEC’s ticker file lists it as OCULAR THERAPEUTIX, INC.

How do I find Ocular Therapeutix, Inc’s 10-K?

Request /api/v1/filings?cik=1393434&form=10-K, or open the company’s EDGAR page and filter by 10-K. Foreign issuers file 20-F or 40-F instead.

Ticker and CIK: SEC company_tickers.json, cached 2026-11-02. Tickers can move between entities; the CIK identifies the filer.

Plain-text version for agents and LLMs: /companies/ocul.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.